Clinical Trial Update: GOAL-Directed ANalgesia (GOALDAN) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for GOAL-Directed ANalgesia (GOALDAN) focused on immediate severe postoperative pain and perioperative hemodynamics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immediate Postoperative Pain
• Perioperative Hemodynamics

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Immediate Severe Postoperative Pain, Perioperative Hemodynamic | Phase 3 | Status: UNKNOWN